Skip to main content
. 2022 May 9;14(9):2335. doi: 10.3390/cancers14092335

Table 5.

Weight, BMI, and laboratory results before and after treatment in the HPV- and HPV+ groups undergoing RT and CRT separately (comparison between HPV groups).

Feature CRT RT
HPV(-) HPV(+) HPV(-) HPV(+)
Weight 0 (kg) 72.60 ± 14.13 78.58 ± 14.92 71.99 ± 17.04 85.53 ± 11.43
Weight 1(kg) 68.96 ± 13.24 72.10 ± 14.71 75.08 ± 13.44 86.73 ± 9.72
p <0.0001 <0.0001 0.004 0.248
p H–B 0.0004 <0.0001 0.062 0.993
BMI 0 (kg/m2) 25.11 ± 4.00 27.78 ± 4.31 26.92 ± 5.69 30.52 ± 3.58
BMI 1 (kg/m2) 23.56 ± 3.21 25.40 ± 4.10 27.91 ± 4.53 30.91 ± 3.47
p <0.0001 <0.0001 0.004 0.248
p H–B 0.0004 <0.0001 0.066 1.000
NRS 2002 0 0.36 ± 0.84 0.20 ± 0.40 0.50 ± 0.93 0.86 ± 1.46
NRS 2002 1 3.06 ± 1.15 3.40 ± 1.12 2.73 ± 0.90 3.33 ± 0.58
p <0.0001 <0.0001 0.004 0.480
p H–B <0.0001 <0.0001 0.058 1.000
CRP 0 (g/L) 7.18 ± 9.76 2.94 ± 3.77 6.02 ± 4.84 6.81 ± 9.24
CRP 1 (g/L) 27.13 ± 35.78 20.66 ± 22.49 38.63 ± 58.38 31.59 ± 30.05
p 0.0014 <0.0001 0.014 1.000
p H–B 0.025 <0.0001 0.167 1.000
Albumin 0 (g/L) 42.05 ± 3.91 41.92 ± 3.93 40.67 ± 2.96 40.71 ± 1.80
Albumin 1 (g/L) 37.23 ± 4.16 37.02 ± 3.77 36.71 ± 4.10 35.57 ± 3.60
p <0.0001 <0.0001 0.004 0.131
p H–B 0.0004 <0.0001 0.062 1.000
Prealbumin 0 (g/L) 0.277 ± 0.079 0.301 ± 0.070 0.230 ± 0.098 0.213 ± 0.029
Prealbumin 1 (g/L) 0.213 ± 0.072 0.217 ± 0.081 0.150 ± 0.048 0.200 ± 0.120
p 0.054 0.0003 0.061 1.000
p H–B 0.543 0.006 0.552 1.000
Hemoglobin 0 (g/dL) 14.08 ± 1.50 13.85 ± 1.56 14.00 ± 1.54 14.09 ± 1.10
Hemoglobin 1 (g/dL) 11.98 ± 1.40 11.82 ± 1.41 12.87 ± 1.41 13.64 ± 1.65
p <0.0001 <0.0001 0.0002 0.221
p H–B <0.0001 <0.0001 0.003 1.000
TLC 0 (/mm3) 1.91 ± 0.78 1.89 ± 0.75 1.91 ± 0.56 1.85 ± 0.57
TLC 1 (/mm3) 0.69 ± 0.47 0.53 ± 0.25 0.74 ± 0.38 0.40 ± 0.16
p <0.0001 <0.0001 <0.0001 0.023
p H–B <0.0001 <0.0001 0.0002 0.257
PNI 0 42.06 ± 3.91 41.93 ± 3.93 40.68 ± 2.96 40.72 ± 1.80
PNI 1 37.23 ± 4.16 37.02 ± 3.77 36.72 ± 4.10 35.57 ± 3.60
p <0.0001 <0.0001 0.004 0.131
p H–B 0.0003 <0.0001 0.058 0.914